[SCHEDULE 13G] Ikena Oncology, Inc. SEC Filing

Rhea-AI Filing Summary

Benchmark Electronics (NYSE: BHE) filed an 8-K announcing the appointment of Charles Swoboda as an independent director effective 4 Aug 2025. Swoboda is best known for leading Cree (now Wolfspeed) as CEO (2001-2017) and Chairman (2002-2017), bringing >20 yrs of semiconductor & LED industry experience. He also serves on Ryder System’s board and is Innovator-in-Residence at Marquette University.

Under the company’s 2025 non-employee director program, Swoboda will receive:

• $70,000 annual cash retainer
• $10,000 Audit & Human Capital/Compensation Committee retainers or $7,500 for Nominating/Sustainability/Governance participation
• Annual RSU grant valued at $170,000

All amounts will be prorated from his start date; the initial RSUs vest on 13 May 2026.

An accompanying press release (Ex. 99.1) was issued the same day. No other material events, financial data, or strategic transactions were disclosed.

Positive

• Adds high-profile industry leader with proven track record scaling Cree/Wolfspeed, which may bolster BHE’s strategic planning and investor confidence.

Negative

• None.

Insights

Corporate Governance Analyst

TL;DR: Seasoned tech executive joins BHE board; governance strengthened, financial impact immaterial.

Swoboda’s two-decade leadership of Cree should enhance BHE’s strategic insight in high-reliability electronics and power semiconductors. His prior public-company board experience aligns with NYSE best-practice independence standards, potentially improving oversight of capital allocation and R&D. Compensation is standard and non-dilutive (prorated RSUs <0.1% of shares). From a governance perspective this is a modest positive, but it is unlikely to move near-term financial metrics.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

IMAGENEBIO, INC.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

45175G207

(CUSIP Number)

07/28/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 45175G207

1

Names of Reporting Persons

Deep Track Capital, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 878,516.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 878,516.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

878,516.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.86 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP No. 45175G207

1

Names of Reporting Persons

Deep Track Biotechnology Master Fund, Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 878,516.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 878,516.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

878,516.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.86 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. 45175G207

1

Names of Reporting Persons

David Kroin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 878,516.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 878,516.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

878,516.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.86 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: IMAGENEBIO, INC.
(b)	Address of issuer's principal executive offices: 12526 High Bluff Drive, Suite 345, San Diego, California 92130
Item 2.
(a)	Name of person filing: (i) Deep Track Capital, LP (ii) Deep Track Biotechnology Master Fund, Ltd. (iii) David Kroin
(b)	Address or principal business office or, if none, residence: (i) 200 Greenwich Ave, 3rd Floor, Greenwich, CT 06830 (ii) c/o Walkers Corporate Limited, 190 Elgin Ave, George Town, KY1-9001, Cayman Islands (iii) c/o Deep Track Capital, LP, 200 Greenwich Ave, 3rd Floor, Greenwich, CT 06830
(c)	Citizenship: (i) Delaware (ii) Cayman Islands (iii) United States
(d)	Title of class of securities: Common Stock, $0.001 par value
(e)	CUSIP No.: 45175G207
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 878,516
(b)	Percent of class: 7.86%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 878,516
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 878,516
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Deep Track Capital, LP is the relevant entity for which David Kroin may be considered a control person.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Deep Track Capital, LP

Signature:	/s/ David Kroin
Name/Title:	David Kroin, Managing Member of the General Partner of the Investment Adviser
Date:	08/04/2025

Deep Track Biotechnology Master Fund, Ltd.

Signature:	/s/ David Kroin
Name/Title:	David Kroin, Director
Date:	08/04/2025

David Kroin

Signature:	/s/ David Kroin
Name/Title:	David Kroin
Date:	08/04/2025

Exhibit Information

Item 4: Information with respect to the Reporting Persons' ownership of the Common Stock as of July 28, 2025, is incorporated by reference to items (5) - (9) and (11) of the cover page of the respective Reporting Person. The amount beneficially owned by each Reporting Person is determined based on 11,181,676 Common Stock outstanding according to the issuer's 8-K filed with the SEC on July 29, 2025. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: August 4, 2025 Deep Track Capital, LP By: /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser Deep Track Biotechnology Master Fund, Ltd. By: /s/ David Kroin David Kroin, Director David Kroin By: /s/ David Kroin David Kroin

FAQ

Who was appointed to Benchmark Electronics' (BHE) board on 4 Aug 2025?

The company appointed Charles Swoboda, former CEO & Chairman of Cree (Wolfspeed).

What compensation will the new BHE director receive?

Swoboda will receive a $70,000 cash retainer plus prorated RSUs worth $170,000 that vest 13 May 2026.

Does the 8-K disclose any financial results or M&A activity?

No, the filing is limited to the board appointment; it contains no earnings, guidance, or transaction data.

When will Charles Swoboda's initial RSU grant vest?

The prorated RSU grant is scheduled to vest on 13 May 2026.

Where can investors find the related press release?

It is filed as Exhibit 99.1 to this 8-K and dated 4 Aug 2025.